Group One Trading
PYXS icon

Group One Trading’s Pyxis Oncology PYXS Stock Holding History

Group One Trading’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1K Sell
10,000
-25,700
-72% -$49.1K ﹤0.01% 5738
2026
Q1 		$52.1K Sell
35,700
-132,500
-79% -$200K ﹤0.01% 5231
2025
Q4 		$193K Buy
168,200
+50,300
+43% +$177K ﹤0.01% 4400
2025
Q3 		$262K Buy
117,900
+103,700
+730% +$149K ﹤0.01% 4383
2025
Q2 		$15.6K Sell
14,200
-600
-4% -$676 ﹤0.01% 6432
2025
Q1 		$14.5K Sell
14,800
-85,400
-85% -$114K ﹤0.01% 6026
2024
Q4 		$156K Buy
+100,200
New +$289K ﹤0.01% 4130
2024
Q2 		– Sell
-20,100
Closed -$85.6K – 7339
2024
Q1 		$85.6K Buy
20,100
+19,900
+9,950% +$83.7K ﹤0.01% 4273
2023
Q4 		$360 Hold
200
– – ﹤0.01% 7122
2023
Q3 		$398 Sell
200
-2,800
-93% -$6.49K ﹤0.01% 7369
2023
Q2 		$7.68K Buy
+3,000
New +$9.52K ﹤0.01% 6523

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's PYXS Position: Q2 2026 in Review

Group One Trading opened a new position in Pyxis Oncology (PYXS) in Q2 2026: 16,480 shares worth $49.6K. The stake represents ﹤0.01% of the portfolio and ranks #5409 among its holdings. This is a return to the name: Group One Trading previously reported a position in PYXS as recently as Q2 2025.

Group One Trading first reported a position in PYXS in Q2 2023 and has held it in 7 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Group One Trading held 16,480 shares of Pyxis Oncology worth $49.6K as of Q2 2026.
  • Pyxis Oncology was a new Group One Trading position in Q2 2026.
  • Pyxis Oncology made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5409 holding.
  • Group One Trading first reported a position in Pyxis Oncology in Q2 2023 and has held it in 7 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.